Customized Characterization Solutions for Different Classes of Antibody Drugs
It has been 35 years since the FDA approved the first monoclonal antibodies in 1986. Antibody drugs have become a major new class of drugs developed in recent years because of their high specificity and low adverse effects. In the last few years, antibodies have become the best-selling drugs in the pharmaceutical market. This field covers monoclonal antibodies, multi-specific antibodies, antibody drug conjugates (ADCs), antibody fusion proteins and small molecule antibodies.
Antibody characterization services and functional studies are critical to delivering the most promising antibody candidates to the clinic. Creative Proteomics has the leading technology and tools to help and support you in meeting these demands.We offer customized and comprehensive characterization services for the following different types of antibody drugs:
